Life ScienceCompany
Jazz Pharmaceuticals M&A Summary
Jazz Pharmaceuticals has acquired 6 companies, including 2 in the last 5 years. A total of 3 acquisitions came from private equity firms. It has also divested 2 assets.
Jazz Pharmaceuticals’ largest acquisition to date was in 2021, when it acquired GW Pharmaceuticals for $6.7B. It’s largest disclosed sale occurred in 2022, when it sold Jazz Pharmaceuticals - Sunosi to Axsome Therapeutics for $53M. Jazz Pharmaceuticals has acquired in 4 different US states, and 3 countries. The Company’s most targeted sectors include life science (100%).
Jazz Pharmaceuticals Business Overview
Where is Jazz Pharmaceuticals headquartered?
Jazz Pharmaceuticals is headquartered in Dublin, Ireland.
What is Jazz Pharmaceuticals’ revenue?
Jazz Pharmaceuticals disclosed revenue of 3,834M USD for 2023 and 3,659M USD for 2022.
How many employees does Jazz Pharmaceuticals have?
Jazz Pharmaceuticals has 2,800 employees.
What sector is Jazz Pharmaceuticals in?
Jazz Pharmaceuticals is a life science company.
When was Jazz Pharmaceuticals founded?
Jazz Pharmaceuticals was founded in 2003.
M&A Summary
-
M&A Total Activity8
- M&A Buy Activity6
- M&A Sell Activity2
- Total Sectors Invested 1
- Total Countries Invested 3
- M&A Buy/Sell Connections 5
- M&A Advisors 9
Unlimited Searches
